Clinical Trial Update: Safety Evaluation of Dexmedetomidine for EBUS-TBNA [Phase 4]

View source ↗

Summary

Phase 4 safety evaluation trial of dexmedetomidine used during EBUS-TBNA for lung cancer; current status is Unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Drugs mentioned

• Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: Maisonneuve-Rosemont Hospital | Conditions: Lung Cancer | Phase 4 | Status: UNKNOWN